Types of Renal Replacement Therapy
Renal replacement therapy consists of three main modalities: intermittent hemodialysis (IHD), continuous renal replacement therapy (CRRT), and prolonged intermittent renal replacement therapy (PIRRT), with no single modality demonstrating superior mortality outcomes in critically ill patients. 1
Primary RRT Modalities
The 2026 multidisciplinary guidelines identify three distinct approaches to RRT in intensive care settings 1:
1. Intermittent Hemodialysis (IHD)
- Duration: 4-6 hours per session
- Mechanism: Rapid solute and fluid removal over shorter periods
- Characteristics: Causes greater shifts in serum osmolality and fluid balance due to concentrated treatment periods
2. Continuous Renal Replacement Therapy (CRRT)
- Duration: Continuous 24-hour treatment
- Mechanism: Stable, gradual solute and fluid removal
- Techniques include:
- Continuous veno-venous hemodialysis (CVVHD) - preferred for small molecule removal and better hemofilter lifespan 2
- Continuous veno-venous hemofiltration (CVVH) - preferred for septic shock, middle-sized molecule removal, and fluid overload 2
- Continuous veno-venous hemodiafiltration (CVVHDF) - most frequently used technique (59% of cases) 2
3. Prolonged Intermittent Renal Replacement Therapy (PIRRT)
- Duration: 6-12 hours per session
- Also known as: Sustained low-efficiency dialysis (SLED)
- Characteristics: Hybrid approach combining advantages of both IHD and CRRT
Comparative Outcomes
Mortality
No mortality difference exists between modalities. The most recent systematic review by Ye et al. (2024) analyzing 30 RCTs with 3,774 patients found a risk ratio of 1.04 (95% CI: 0.93-1.18) when comparing CRRT to IHD 1. For PIRRT versus CRRT, four of six systematic reviews found no significant difference, while two suggested slight survival benefit for PIRRT, though data remain too heterogeneous for definitive conclusions 1.
Renal Recovery
Controlled trials show no difference in renal recovery between modalities, but large observational studies suggest potential advantages for CRRT 1. The STARRT-AKI post-hoc analysis (n=2,196) showed improved renal recovery with CRRT at 90 days (OR 0.61; 95% CI 0.39-0.94), though modality assignment was not randomized 1. French data involving 25,750 cases demonstrated better recovery with CRRT (OR 0.91; 95% CI 0.83-0.99) 1.
Hemodynamic Stability
CRRT provides superior hemodynamic stability compared to IHD 1. This represents the primary clinical advantage where modality selection impacts patient management, particularly in hemodynamically unstable patients.
Clinical Decision Algorithm
For hemodynamically unstable patients: Use CRRT due to continuous, gradual fluid and solute removal minimizing cardiovascular stress.
For hemodynamically stable patients: Any modality (IHD, CRRT, or PIRRT) is acceptable, as no mortality difference exists 1.
For fluid overload management: All three modalities can achieve negative fluid balance effectively 1.
For early mobilization needs: CRRT should not prevent or delay early mobilization (expert consensus) 1.
Additional RRT Options Beyond ICU Setting
For chronic kidney disease requiring long-term RRT 3:
- Peritoneal dialysis: Requires surgically implanted abdominal catheter
- Kidney transplantation: Definitive treatment option
- Conservative management: Valid alternative approach for selected patients
Important Caveats
The choice between modalities should be guided by hemodynamic status rather than anticipated mortality benefit, as all three modalities demonstrate equivalent survival outcomes 1. The suggestion of improved renal recovery with CRRT comes primarily from observational data with significant selection bias and center preferences, not from randomized controlled trials 1.
Worldwide practice patterns show substantial heterogeneity, with 97% of ICUs having CRRT capability versus 85% having IHD access, and 70% of units offering at least two CRRT techniques 2. This diversity reflects the lack of definitive evidence favoring one approach over another for most clinical scenarios.